Pharmacogenomics & Personalized Medicine

Pharmacogenomics & Personalized Medicine

药物基因组学和个性化医学

  • 4区 中科院分区
  • Q3 JCR分区

期刊简介

《Pharmacogenomics & Personalized Medicine》是由Dove Medical Press出版社创办的英文国际期刊(ISSN: 1178-7066,E-ISSN: 1178-7066),该期刊长期致力于药学领域的创新研究,主要研究方向为Biochemistry, Genetics and Molecular Biology-Molecular Medicine。作为SCIE收录期刊(JCR分区 Q3,中科院 4区),本刊采用OA开放获取模式(OA占比1%),以发表药学领域等方向的原创性研究为核心(研究类文章占比86.02%%)。凭借严格的同行评审与高效编辑流程,期刊年载文量精选控制在93篇,确保学术质量与前沿性。成果覆盖Web of Science、Scopus等国际权威数据库,为学者提供推动医学领域高水平交流平台。

投稿咨询

投稿提示

Pharmacogenomics & Personalized Medicine审稿周期约为 16 Weeks 。该刊近年未被列入国际预警名单,年发文量约93篇,录用竞争适中,主题需确保紧密契合医学前沿。投稿策略提示:避开学术会议旺季投稿以缩短周期,语言建议专业润色提升可读性。

  • 医学 大类学科
  • English 出版语言
  • 是否预警
  • SCIE 期刊收录
  • 93 发文量

中科院分区

中科院 SCI 期刊分区 2023年12月升级版

Top期刊 综述期刊 大类学科 小类学科
医学
4区
PHARMACOLOGY & PHARMACY 药学
4区

中科院 SCI 期刊分区 2022年12月升级版

Top期刊 综述期刊 大类学科 小类学科
医学
4区
PHARMACOLOGY & PHARMACY 药学
4区

JCR分区

按JIF指标学科分区 收录子集 分区 排名 百分位
学科:PHARMACOLOGY & PHARMACY SCIE Q3 240 / 354

32.3%

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:PHARMACOLOGY & PHARMACY SCIE Q3 215 / 354

39.41%

CiteScore

CiteScore SJR SNIP CiteScore 排名
CiteScore:3.3 SJR:0.508 SNIP:0.544
学科类别 分区 排名 百分位
大类:Pharmacology, Toxicology and Pharmaceutics 小类:Pharmacology Q3 199 / 313

36%

大类:Pharmacology, Toxicology and Pharmaceutics 小类:Molecular Medicine Q3 134 / 178

25%

期刊发文

  • Resistance to PARP Inhibitors After First-Line Platinum-Based Chemotherapy in a Patient with Advanced Ovarian Cancer with a Pathogenic Somatic BRCA1 Mutation

    Author: Zhong, Lan; Yin, Rutie; Song, Liang

    Journal: PHARMACOGENOMICS & PERSONALIZED MEDICINE. 2023; Vol. 16, Issue , pp. 195-200. DOI: 10.2147/PGPM.S397827

  • Identification and Validation of Ferroptosis-Related Subtypes and a Predictive Signature in Hepatocellular Carcinoma

    Author: Zheng, Chunlan; Peng, Yanan; Wang, Haizhou; Wang, Youwei; Liu, Lan; Zhao, Qiu

    Journal: PHARMACOGENOMICS & PERSONALIZED MEDICINE. 2023; Vol. 16, Issue , pp. 39-58. DOI: 10.2147/PGPM.S397892

  • NOTCH2, ATIC, MRI1, SLC6A13, ATP13A2 Genetic Variations are Associated with Ventricular Septal Defect in the Chinese Tibetan Population Through Whole-Exome Sequencing

    Author: Zhang, Xiaohui; Zhen, Da; Li, Xuemei; Yi, Faling; Zhang, Zhanhao; Yang, Wei; Li, Xuguang; Sheng, Yemeng; Liu, Xiaoli; Jin, Tianbo; He, Yongjun

    Journal: PHARMACOGENOMICS & PERSONALIZED MEDICINE. 2023; Vol. 16, Issue , pp. 389-400. DOI: 10.2147/PGPM.S404438

  • The Allelic Expression of RNA Editing Gene ADARB1 in Hepatocellular Carcinoma Treated with Transarterial Chemoembolization

    Author: Zeng, Jiajia; Han, Linyu; Wang, Teng; Huang, Linying; Zheng, Yanxiu; Zhang, Nasha; Li, Ziqiang; Yang, Ming

    Journal: PHARMACOGENOMICS & PERSONALIZED MEDICINE. 2023; Vol. 16, Issue , pp. 229-238. DOI: 10.2147/PGPM.S402115

  • LncRNA FOXD2-AS1 Increased Proliferation and Invasion of Lung Adenocarcinoma via Cell-Cycle Regulation

    Author: Yuan, Yuan; Yu, Peng; Shen, Huihua; Xing, Guozhu; Li, Wu

    Journal: PHARMACOGENOMICS & PERSONALIZED MEDICINE. 2023; Vol. 16, Issue , pp. 99-109. DOI: 10.2147/PGPM.S396866

  • Dysregulation of circRNA-0076906 and circRNA-0134944 is Correlated with Susceptibility to Osteoporosis and Osteoporotic Fracture in Postmenopausal Females from the Chinese Han Population

    Author: Yang, Weijie; Zhang, Wei; Li, Fengqian; Xu, Ning; Sun, Ping

    Journal: PHARMACOGENOMICS & PERSONALIZED MEDICINE. 2023; Vol. 16, Issue , pp. 183-194. DOI: 10.2147/PGPM.S394757

  • Massive Hepatocellular Carcinoma with Situs Inversus Totalis Achieved a Complete Response Following Camrelizumab Plus Apatinib and Combined with Two-Stage Hepatectomy: A Case Report

    Author: Wu, Yining; Ou, Shenjian; Liao, Xiwen; Han, Chuangye; Yang, Chengkun; Qin, Wei; Tan, Yufeng; Lao, Quan; Peng, Tao; Ye, Xinping

    Journal: PHARMACOGENOMICS & PERSONALIZED MEDICINE. 2023; Vol. 16, Issue , pp. 111-120. DOI: 10.2147/PGPM.S376596

  • Acute Myeloid Leukemia Secondary to Chronic Lymphocytic Leukemia After Prolonged Chlorambucil Therapy: A Case Report

    Author: Wu, Yan; Liu, Shan; Wang, Dongmei; Yao, Xinjie

    Journal: PHARMACOGENOMICS & PERSONALIZED MEDICINE. 2023; Vol. 16, Issue , pp. 401-405. DOI: 10.2147/PGPM.S407940